Cancer	B:C0334227
cells	I:C0334227
exhibit	O
clonal	O
diversity	O
in	O
phenotypic	O
plasticity	O
Phenotypic	O
heterogeneity	I:C1852220
in	O
cancers	O
is	O
associated	O
with	O
invasive	O
progression	O
and	O
drug	O
resistance	I:C0013203
.	O

Cancer	O
cells	I:C0334227
exhibit	O
clonal	O
diversity	O
in	O
phenotypic	O
plasticity	O
Phenotypic	B:C1852220
heterogeneity	I:C1852220
in	O
cancers	O
is	O
associated	O
with	O
invasive	O
progression	O
and	O
drug	O
resistance	I:C0013203
.	O

Cancer	O
cells	I:C0334227
exhibit	O
clonal	O
diversity	O
in	O
phenotypic	O
plasticity	O
Phenotypic	O
heterogeneity	I:C1852220
in	O
cancers	B:C0006826
is	O
associated	O
with	O
invasive	O
progression	O
and	O
drug	O
resistance	I:C0013203
.	O

Cancer	O
cells	I:C0334227
exhibit	O
clonal	O
diversity	O
in	O
phenotypic	O
plasticity	O
Phenotypic	O
heterogeneity	I:C1852220
in	O
cancers	O
is	O
associated	O
with	O
invasive	O
progression	B:C0178874
and	O
drug	O
resistance	I:C0013203
.	O

Cancer	O
cells	I:C0334227
exhibit	O
clonal	O
diversity	O
in	O
phenotypic	O
plasticity	O
Phenotypic	O
heterogeneity	I:C1852220
in	O
cancers	O
is	O
associated	O
with	O
invasive	O
progression	O
and	O
drug	B:C0013203
resistance	I:C0013203
.	O

This	O
heterogeneity	O
arises	O
in	O
part	O
from	O
the	O
ability	O
of	O
cancer	B:C0334227
cells	I:C0334227
to	O
switch	O
between	O
phenotypic	O
states	O
,	O
but	O
the	O
dynamics	O
of	O
this	O
cellular	O
plasticity	I:C4042875
remain	O
poorly	O
understood	O
.	O

This	O
heterogeneity	O
arises	O
in	O
part	O
from	O
the	O
ability	O
of	O
cancer	O
cells	I:C0334227
to	O
switch	O
between	O
phenotypic	O
states	O
,	O
but	O
the	O
dynamics	O
of	O
this	O
cellular	B:C4042875
plasticity	I:C4042875
remain	O
poorly	O
understood	O
.	O

Here	O
we	O
apply	O
DNA	B:C2936548
barcodes	I:C2936548
to	O
quantify	O
and	O
track	O
phenotypic	O
plasticity	O
across	O
hundreds	O
of	O
clones	O
in	O
a	O
population	O
of	O
cancer	O
cells	I:C0334227
exhibiting	O
epithelial	O
or	O
mesenchymal	O
differentiation	O
phenotypes	O
.	O

Here	O
we	O
apply	O
DNA	O
barcodes	I:C2936548
to	O
quantify	O
and	O
track	O
phenotypic	O
plasticity	O
across	O
hundreds	O
of	O
clones	B:C0009013
in	O
a	O
population	O
of	O
cancer	O
cells	I:C0334227
exhibiting	O
epithelial	O
or	O
mesenchymal	O
differentiation	O
phenotypes	O
.	O

Here	O
we	O
apply	O
DNA	O
barcodes	I:C2936548
to	O
quantify	O
and	O
track	O
phenotypic	O
plasticity	O
across	O
hundreds	O
of	O
clones	O
in	O
a	O
population	B:C1257890
of	O
cancer	O
cells	I:C0334227
exhibiting	O
epithelial	O
or	O
mesenchymal	O
differentiation	O
phenotypes	O
.	O

Here	O
we	O
apply	O
DNA	O
barcodes	I:C2936548
to	O
quantify	O
and	O
track	O
phenotypic	O
plasticity	O
across	O
hundreds	O
of	O
clones	O
in	O
a	O
population	O
of	O
cancer	B:C0334227
cells	I:C0334227
exhibiting	O
epithelial	O
or	O
mesenchymal	O
differentiation	O
phenotypes	O
.	O

We	O
find	O
that	O
the	O
epithelial	O
-	O
to	O
-	O
mesenchymal	O
cell	O
ratio	O
is	O
highly	O
variable	O
across	O
the	O
different	O
clones	B:C0009013
in	O
cancer	O
cell	I:C0334227
populations	O
,	O
but	O
remains	O
stable	O
for	O
many	O
generations	O
within	O
the	O
progeny	O
of	O
any	O
single	O
clone	O
-	O
with	O
a	O
heritability	O
of	O
0.89	O
.	O

We	O
find	O
that	O
the	O
epithelial	O
-	O
to	O
-	O
mesenchymal	O
cell	O
ratio	O
is	O
highly	O
variable	O
across	O
the	O
different	O
clones	O
in	O
cancer	B:C0334227
cell	I:C0334227
populations	O
,	O
but	O
remains	O
stable	O
for	O
many	O
generations	O
within	O
the	O
progeny	O
of	O
any	O
single	O
clone	O
-	O
with	O
a	O
heritability	O
of	O
0.89	O
.	O

We	O
find	O
that	O
the	O
epithelial	O
-	O
to	O
-	O
mesenchymal	O
cell	O
ratio	O
is	O
highly	O
variable	O
across	O
the	O
different	O
clones	O
in	O
cancer	O
cell	I:C0334227
populations	B:C1257890
,	O
but	O
remains	O
stable	O
for	O
many	O
generations	O
within	O
the	O
progeny	O
of	O
any	O
single	O
clone	O
-	O
with	O
a	O
heritability	O
of	O
0.89	O
.	O

We	O
find	O
that	O
the	O
epithelial	O
-	O
to	O
-	O
mesenchymal	O
cell	O
ratio	O
is	O
highly	O
variable	O
across	O
the	O
different	O
clones	O
in	O
cancer	O
cell	I:C0334227
populations	O
,	O
but	O
remains	O
stable	O
for	O
many	O
generations	O
within	O
the	O
progeny	O
of	O
any	O
single	O
clone	B:C0009013
-	O
with	O
a	O
heritability	O
of	O
0.89	O
.	O

To	O
estimate	O
the	O
effects	O
of	O
combination	O
therapies	O
on	O
phenotypically	B:C0027651
heterogeneous	I:C0027651
tumours	I:C0027651
,	O
we	O
generated	O
quantitative	O
simulations	I:C0679083
incorporating	O
empirical	O
data	O
from	O
our	O
barcoding	O
experiments	I:C0681814
.	O

To	O
estimate	O
the	O
effects	O
of	O
combination	O
therapies	O
on	O
phenotypically	O
heterogeneous	I:C0027651
tumours	I:C0027651
,	O
we	O
generated	O
quantitative	B:C0679083
simulations	I:C0679083
incorporating	O
empirical	O
data	O
from	O
our	O
barcoding	O
experiments	I:C0681814
.	O

To	O
estimate	O
the	O
effects	O
of	O
combination	O
therapies	O
on	O
phenotypically	O
heterogeneous	I:C0027651
tumours	I:C0027651
,	O
we	O
generated	O
quantitative	O
simulations	I:C0679083
incorporating	O
empirical	O
data	O
from	O
our	O
barcoding	B:C0681814
experiments	I:C0681814
.	O

These	O
analyses	O
indicated	O
that	O
combination	O
therapies	O
which	O
alternate	O
between	O
epithelial	O
-	O
and	O
mesenchymal	O
-	O
specific	B:C0087111
treatments	I:C0087111
eventually	O
select	O
for	O
clones	O
with	O
increased	O
phenotypic	O
plasticity	O
.	O

These	O
analyses	O
indicated	O
that	O
combination	O
therapies	O
which	O
alternate	O
between	O
epithelial	O
-	O
and	O
mesenchymal	O
-	O
specific	O
treatments	I:C0087111
eventually	O
select	O
for	O
clones	B:C0009013
with	O
increased	O
phenotypic	O
plasticity	O
.	O

However	O
,	O
this	O
selection	O
could	O
be	O
minimized	O
by	O
increasing	O
the	O
frequency	O
of	O
alternation	O
between	O
treatments	B:C0087111
,	O
identifying	O
designs	O
that	O
may	O
minimize	O
selection	O
for	O
increased	O
phenotypic	O
plasticity	O
.	O

These	O
findings	O
establish	O
new	O
insights	O
into	O
phenotypic	O
plasticity	O
in	O
cancer	B:C0006826
,	O
and	O
suggest	O
design	O
principles	O
for	O
optimizing	O
the	O
effectiveness	O
of	O
combination	O
therapies	O
for	O
phenotypically	O
heterogeneous	I:C0027651
tumours	I:C0027651
.	O

These	O
findings	O
establish	O
new	O
insights	O
into	O
phenotypic	O
plasticity	O
in	O
cancer	O
,	O
and	O
suggest	O
design	O
principles	O
for	O
optimizing	O
the	O
effectiveness	O
of	O
combination	O
therapies	O
for	O
phenotypically	B:C0027651
heterogeneous	I:C0027651
tumours	I:C0027651
.	O

